BBC Among Health Care ETFs
End-of-day Nov 20, 2026 · 39 Health care ETFs by 1M
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −4.1% | −10.3% | −9.4% | −29.5% | −1.1% | +14.8% | +110.2% | −13.1% | +90.4% | +49.6% |
| Peer average | −1.3% | −6.4% | −4.5% | −5.9% | +13.4% | +17.5% | +58.2% | +19.5% | +146.1% | — |
| S&P 500 · VOO | −3.4% | −8.3% | −9.5% | −9.2% | +2.2% | +5.5% | +59.8% | +58.7% | +275.8% | — |
$24 of every $1,000 in BBC is Kodiak
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | KODKodiak Sciences | Healthcare | 2.41% | $241.23 | 7,839 | $767K |
| 2 | XNCRXencor | Healthcare | 2.31% | $231.47 | 22K | $736K |
| 3 | TRAXFirst Tracks Biotherapeutics | Healthcare | 2.12% | $211.52 | 15K | $673K |
| 4 | REPLReplimune Group | Healthcare | 1.82% | $181.73 | 30K | $578K |
| 5 | ABCLAbCellera Biologics | Healthcare | 1.68% | $167.67 | 51K | $533K |
| 6 | VRDNViridian Therapeutics | Healthcare | 1.61% | $161.37 | 16K | $513K |
| 7 | SLSSELLAS Life Sciences Group | Healthcare | 1.59% | $159.27 | 34K | $507K |
| 8 | AMLXAmylyx Pharmaceuticals | Healthcare | 1.51% | $150.69 | 18K | $479K |
| 9 | SGPSpyGlass Pharma | Healthcare | 1.40% | $140.08 | 14K | $446K |
| 10 | MBXMBX Biosciences | Healthcare | 1.26% | $126.23 | 7,519 | $402K |
| 11 | LBRXLB Pharmaceuticals | Healthcare | 1.18% | $118.23 | 9,394 | $376K |
| 12 | ORKAOruka Therapeutics | Healthcare | 1.17% | $117.16 | 3,820 | $373K |
| 13 | KYMRKymera Therapeutics | Healthcare | 1.16% | $116.23 | 3,097 | $370K |
| 14 | PRMEPrime Medicine | Healthcare | 1.16% | $116.12 | 96K | $369K |
| 15 | CGONCG Oncology | Healthcare | 1.15% | $115.46 | 4,485 | $367K |
of the $110B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | KOD | Kodiak Sciences | 2.41% |
| 2 | XNCR | Xencor | 2.31% |
| 3 | TRAX | First Tracks Biotherapeutics | 2.12% |
| 4 | REPL | Replimune Group | 1.82% |
| 5 | ABCL | AbCellera Biologics | 1.68% |
| 6 | VRDN | Viridian Therapeutics | 1.61% |
| 7 | SLS | SELLAS Life Sciences Group | 1.59% |
| 8 | AMLX | Amylyx Pharmaceuticals | 1.51% |
| 9 | SGP | SpyGlass Pharma | 1.40% |
| 10 | MBX | MBX Biosciences | 1.26% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 22, 2025 | Dec 29, 2025 | $0.66 |
| Dec 20, 2024 | Dec 27, 2024 | $0.24 |
| Dec 20, 2023 | Dec 29, 2023 | $0.0823 |
| Dec 20, 2017 | Dec 27, 2017 | $0.30 |
| Dec 21, 2015 | Dec 29, 2015 | $0.15 |